st2 and reg3α as predictive biomarkers for gvhd
Published 1 year ago • 66 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
3:35
role of the microbiome in gvhd
-
4:22
management of acute gvhd
-
3:35
role of the microbiome in gvhd
-
1:12
managing gvhd in patients undergoing sct
-
6:15
standardizing chronic gvhd grading and assessment
-
2:51
reg3α as a biomarker and therapeutic target for gvhd
-
0:46
2d vs 3d mammograms
-
10:24
b-t cell interactions in gvhd
-
1:58
what are the side effects after stem cell therapy 1 (844) get-stem
-
1:32
understanding the role of nrft2 signaling in hepatitis infections and liver cancer
-
27:05
dual energy ct of the pancreas
-
0:49
advances in gvhd and maintenance following transplant
-
4:13
understanding risk factors, biomarkers, and prognostic scores for gvhd preemptive therapy
-
2:05
using engineered t-cells to suppress acute gvhd and leukemia relapse after allosct
-
6:26
wog s1011: standard vs extended lymphadenectomy in radical cystectomy - phase iii trial | crsf 2024
-
8:57
outcomes of sct in t-all and t-lbl
-
0:48
health ministry: 2,643 new cases, four new clusters linked to workplaces
-
1:07
hat2028rj-vb is a 2 n-channel sop8 package mos tube
-
3:40
master class in transplantation and hematology: highlights
-
4:38
phase i study of neihulizumab in patients with sr-agvhd or tr-agvhd
-
3:30
targeting t-cell, b-cell & apc activation to treat chronic gvhd
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml